Genexine Inc Cash Flow Reinvestment Rate

Latest as of March 2025: 9.89x

Genexine Inc cash flow reinvestment rate. Genexine Inc (095700) has a Cash Flow Reinvestment Rate of 9.89x as of March 2025, reinvesting ₩7.91 Billion (capex ₩3.89 Billion plus investments ₩-4.01 Billion) from operating cash flow of ₩799.82 Million. Explore Genexine Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

9.89x
(Capex + Investments) / Operating CF

Total Reinvested

₩7.91 Billion
Capex + Investments

Operating Cash Flow

₩799.82 Million
KRW

Capital Expenditures

₩3.89 Billion
KRW

Cash Flow Reinvestment Rate of Genexine Inc (2009–2012)

Cash flow reinvestment rate of Genexine Inc from 2009 to 2012. Historical reinvestment intensity for Genexine Inc across 2 annual periods. Explore 095700 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Genexine Inc Cash Flow Reinvestment Rate by Year (2009–2012)

Genexine Inc cash flow reinvestment rate by year from 2009 to 2012. Year-by-year capital reinvestment analysis for Genexine Inc. For the full cash flow conversion analysis, see cash flow conversion of Genexine Inc.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2012 12.61x ₩21.04 Billion ₩1.67 Billion ₩2.42 Billion ▼ -98.2%
2009 683.23x ₩24.07 Billion ₩35.23 Million ₩1.03 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow